Valuation: Guerbet

Market Cap 111M 127M 104M 95.06M 179M 12.21B 181M 1.23B 481M 6B 476M 466M 20.76B P/E 2026 *
-248x
P/E 2027 * 5.49x
Enterprise Value 405M 461M 377M 346M 649M 44.4B 659M 4.47B 1.75B 21.83B 1.73B 1.69B 75.47B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.96%
1 day-6.68%
1 week-8.04%
Current month-8.95%
1 month-10.24%
3 months-29.09%
6 months-40.46%
Current year-42.38%
1 week 8.21
Extreme 8.21
9.18
1 month 8.21
Extreme 8.21
9.65
Current year 8.01
Extreme 8.01
15.12
1 year 8.01
Extreme 8.01
23.1
3 years 8.01
Extreme 8.01
40.25
5 years 8.01
Extreme 8.01
45.65
10 years 8.01
Extreme 8.01
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 49 19/05/2017
Director/Board Member 51 22/11/2023
Date Insider Type Main position Quantity % Market Cap.
13/11/25 Buy

Director

1,100 0.0087%
13/11/25 Buy

Director

90 0.0007%
10/10/25 Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-6.68%-8.04%-64.17%-58.51% 127M
-3.58%-1.75%-17.76%-19.58% 13.78B
-0.07%-4.54%+43.53%-8.66% 3.94B
-3.46%-8.35%-41.64%-61.88% 1.18B
+0.77%-2.49%+67.16%+108.58% 1.2B
-1.62%-6.53%-41.29%-48.24% 1.09B
-3.98%-8.02%-46.54% - 936M
-3.75%-16.04%+36.75%+72.97% 467M
+0.83%+0.07%+57.26% - 330M
-1.90%-1.62%-60.80%+228.43% 261M
Average -2.34%-2.14%-6.75%+26.64% 2.33B
Weighted average by Cap. -2.62%-4.22%-5.06%-9.66%

Financials

2026 *2027 *
Net sales 754M 858M 701M 643M 1.21B 82.65B 1.23B 8.32B 3.25B 40.63B 3.22B 3.15B 140B 796M 907M 740M 679M 1.28B 87.3B 1.3B 8.79B 3.44B 42.92B 3.4B 3.33B 148B
Net income -1.62M -1.84M -1.5M -1.38M -2.59M -177M -2.63M -17.86M -6.98M -87.17M -6.91M -6.76M -301M 29.08M 33.11M 27.04M 24.82M 46.63M 3.19B 47.35M 321M 125M 1.57B 124M 122M 5.42B
Net Debt 294M 334M 273M 250M 471M 32.18B 478M 3.24B 1.27B 15.82B 1.25B 1.23B 54.71B 277M 316M 258M 237M 445M 30.41B 452M 3.06B 1.2B 14.95B 1.19B 1.16B 51.69B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
25/07/26 EUR 8.240 -6.68% 57,840
23/07/26 EUR 8.830 -0.67% 5,451
22/07/26 EUR 8.890 +0.68% 14,198
21/07/26 EUR 8.830 +0.80% 11,686
20/07/26 EUR 8.760 -2.23% 15,066
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.830EUR
Average target price
11.60EUR
Spread / Average Target
+31.37%

Quarterly revenue - Rate of surprise